Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2025.
Thermo Fisher Scientific on Thursday beat Wall Street estimates for fourth-quarter profit and revenue on strong demand for ...
Thusday morning, Thermo Fisher Scientific, which has a laboratory in Center Valley and also an Allentown location, reported ...
Thermo Fisher Scientific Inc.'s TMO fourth-quarter 2025 adjusted earnings per share (EPS) of $6.57 beat the Zacks Consensus ...
Q4 2025 Management View Marc Casper, Chairman, President & CEO, emphasized, "We delivered a strong year, capped off by an ...
Q4 2025 Earnings Call January 29, 2026 8:30 AM EST Good morning, ladies and gentlemen, and welcome to the Thermo Fisher ...
Thermo Fisher beat Q4 earnings and revenue estimates, driven by life sciences growth, and forecast 4%–6% revenue growth with ...
Thermo Fisher and NVIDIA collaborate to integrate AI into scientific research, enhancing laboratory automation and efficiency. Thermo Fisher Scientific has entered a strategic collaboration with ...
Thermo Fisher Scientific has received a total of 8 ratings from analysts, with the consensus rating as Buy. With an average ...
Thermo Fisher Scientific: recent gains put performance in focus Thermo Fisher Scientific (TMO) has drawn investor attention ...
Investing.com - Thermo Fisher Scientific (NYSE: TMO) reported fourth quarter EPS of $6.57, $0.12 better than the analyst estimate of $6.45. Revenue for the quarter came in at $12.21B versus the ...
The large laboratory equipment supplier had grown its Western North Carolina site during the pandemic.